InsidersTradesSigma
Explore the detailed record of transactions filed by Slilaty Steve N., Chief Executive Officer. Insider active across 1 companies, notably Sunshine Biopharma, Inc. Aggregated, 1 disclosures have been published. The latest transaction was filed on 18 February 2022 — Disposition. Regulator: SEC (Form 4). The full history is free.
1 of 1 declaration
Steve N. Slilaty is the Chief Executive Officer of Sunshine Biopharma, Inc. In this role, he is responsible for the strategic and operational leadership of the company. Steve brings extensive experience in the biopharmaceutical sector, contributing to innovation and growth at Sunshine Biopharma. His leadership is essential to achieve the company's objectives and ensure its sustainability.